Efavirenz

Thông số

154598-52-4Số CAS

620-492-6Số EC

(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-oneTên IUPAC

C14H9ClF3NO2Công thức hóa học

315.67 g/molKhối lượng phân tử

efavirenz; 154598-52-4; Sustiva; Stocrin; DMP-266; (-)-Efavirenz; (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; Viraday; Efavirenz teva; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; L-743726; Efavirenzum; DTXSID9046029; L-743,726; NSC-742403; JE6H2O27P8; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; CHEBI:119486; DTXCID7026029; TELURA COMPONENT EFAVIRENZ; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; (s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo(d)(1,3)oxazin-2-one; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo(d)(1,3)oxazin-2-one; efavirenz, (S)-; Sustiva 600; RefChem:590606; J05AG03; EFAVIRENZ 200MG SCORED TABLETS; MK-0831; L743726; L 743,726; DMP 266; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; EFV; (S)-Efavirenz; MFCD05662344; (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE; DMP266; (Rac)-Efavirenz; NSC742403; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-; (Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726; Eravirenz; (S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one; SMR000466351; Strocin (TM); Sustiva (TM); Sustiva (TN); CAS-154598-52-4; HSDB 7163; SR-01000759360; L 743726; Efavirenz [USP:INN:BAN]; UNII-JE6H2O27P8; s4685; Efavirenz RS; Met-SDF-1.beta. & Efavirenz; 1ikv; 1ikw; NCGC00159337-02; Efavirenz, (S); Efavirenz & PLGA; Efavirenz (Standard); Efavirenz & IFNL1; Efavirenz & IFNL2; Efavirenz & IFNL3; Efavirenz & IL-29; Efavirenz 100 microg/mL in Acetonitrile; EFAVIRENZ [INN]; EFAVIRENZ [JAN]; DMP-266; Efavirenz; Efavirenz & IL-28A; Efavirenz & IL-28B; EFAVIRENZ [MI]; EFAVIRENZ [HSDB]; EFAVIRENZ [USAN]; EFV & Interleukin 29; EFAVIRENZ [VANDF]; EFV & Interleukin 28A; EFV & Interleukin 28B; EFV & PLGA; EFAVIRENZ [MART.]; Epitope ID:231718; EFAVIRENZ [USP-RS]; EFAVIRENZ [WHO-DD]; EFAVIRENZ [WHO-IP]; EFV & IFNL1; EFV & IFNL2; EFV & IFNL3; Efavirenz (JAN/USP/INN); EFV & Interferon lambda-1; EFV & Interferon lambda-2; EFV & Interferon lambda-3; Efavirenz & Interleukin 29; SCHEMBL37762; EFAVIRENZ [EMA EPAR]; Efavirenz & Interleukin 28A; Efavirenz & Interleukin 28B; MLS000759465; MLS001424087; BIDD:GT0383; Efavirenz - Bio-X trade mark; BDBM2483; CHEMBL223228; EFV & IL-28A; EFV & IL-28B; orb1305550; orb3141258; EFAVIRENZ [ORANGE BOOK]; Efavirenz, >=98% (HPLC); Efavirenz & Interferon lambda-1; Efavirenz & Interferon lambda-2; Efavirenz & Interferon lambda-3; EFV & IL-29; GTPL11287; EFAVIRENZ [USP MONOGRAPH]; ATRIPLA COMPONENT EFAVIRENZ; GLXC-04867; HMS2051J08; HMS2090N16; HMS3393J08; HMS3713M14; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; EFAVIRENZUM [WHO-IP LATIN]; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-; ALBB-038626; MSK10874; Tox21_111582; DL-535; EBC-12705; HY-10572R; AKOS015894951; Tox21_111582_1; AB21723; CCG-101011; DB00625; FC30275; KS-5380; NC00261; NSC 742403; NCGC00159337-04; NCGC00159337-12; NCGC00271713-05; NCGC00271713-08; AC-25006; BC164402; HY-10572; SY009682; E0997; E2003; NS00000604; T2393; C08088; D00896; EN300-219935; F17329; AB00639956-06; AB00639956-08; F794608; Q422645; SR-01000759360-4; SR-01000759360-5; BRD-K40758068-001-08-2; Z2177953192; Efavirenz, United States Pharmacopeia (USP) Reference Standard; 2H-3, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-; (S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one; (S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one; (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-oneTên gọi khác